AI
Monday, June 25, 2012 6:53:03 PM
Sorry don't know the answers. I didn't listen to the presentation just got the slides from a Genzyme tweet. I know Henri was extremely bullish on it but he was(is) likely a bit biased 
. I don't recall exact pricing but know there have been articles published speculating on what Genzyme would do since Campath was already on the market. It seemed it wouldn't be priced comparable though (too low).
. I don't recall exact pricing but know there have been articles published speculating on what Genzyme would do since Campath was already on the market. It seemed it wouldn't be priced comparable though (too low).
Trade Smarter with Thousands
Leverage decades of market experience shared openly.
